Oric Pharmaceuticals, Inc. (ORIC) Operating income 2018–2025
Oric Pharmaceuticals, Inc. (ORIC) annual operating income history from SEC filings — each fiscal year as reported.
-$143.0MFY2025 · since FY2018: -$22.4M → -$143.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$143.0M | -0.1% |
| FY2024 | -$142.9M | -29.0% |
| FY2023 | -$110.8M | -20.7% |
| FY2022 | -$91.8M | -16.4% |
| FY2021 | -$78.9M | -6.3% |
| FY2020 | -$74.2M | -159.7% |
| FY2019 | -$28.6M | -27.7% |
| FY2018 | -$22.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice